CompletedNot Applicable

Serum Uromodulin and DN Systematic Review and Meta Analysis

Egypt1,774 participantsStarted 2024-05-01

Plain-language summary

Several studies have investigated the association between the changes of serum uromodulin and diabetic nephropathy (DN). However, the results are still controversial. Hence, this meta-analysis aimed to evaluate the association of uromodulin with DN.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. serum level of uromodulin was determined;
. the samples were enrolled from diabetic patients;
. mean ± SD was reported for uromodulin between patients with and without DN;
. the level of albumin to creatinine ratio (ACR), glomerular filtration rate (GFR), or albumin excretion rate (AER) in patients with DN was determined

Exclusion criteria

. duplicate studies;
. review articles;
. non original research articles;
. studies with insufficient data to extract;
. non-human research;
. studies that determined urine level of uromodulin.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Association of serum uromodulin with DKD: asystematic review and meta analysis

Timeframe: may, 2024

Trial details

NCT IDNCT06596863

SponsorTanta University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-05-30

View on ClinicalTrials.gov More Diabetic Nephropathies trials

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. serum level of uromodulin was determined;
. the samples were enrolled from diabetic patients;
. mean ± SD was reported for uromodulin between patients with and without DN;
. the level of albumin to creatinine ratio (ACR), glomerular filtration rate (GFR), or albumin excretion rate (AER) in patients with DN was determined

Exclusion criteria

. duplicate studies;
. review articles;
. non original research articles;
. studies with insufficient data to extract;
. non-human research;
. studies that determined urine level of uromodulin.